Clinical Trials Browser

OTHER × envafolimab × Genitourinary × Clear all

NCT07159191 2025-09-08

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Phase 2 Not yet recruiting

Advanced Renal Cell Carcinoma (aRCC)

NCT06663007 2024-10-29

RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure

Phase 1/2 Recruiting

Prostatic Neoplasms